Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1809 1
1810 1
1815 1
1819 2
1843 1
1852 2
1853 1
1887 1
1889 3
1892 1
1893 2
1894 1
1897 2
1898 1
1899 1
1900 1
1902 5
1903 4
1904 1
1905 3
1906 1
1908 3
1909 2
1910 3
1911 3
1912 3
1913 2
1914 1
1915 1
1916 10
1918 1
1919 2
1920 2
1921 1
1922 2
1923 2
1925 1
1928 2
1929 1
1930 3
1931 5
1932 8
1933 1
1934 1
1935 3
1936 3
1937 1
1938 1
1939 1
1940 3
1941 1
1942 2
1944 1
1945 4
1946 11
1947 15
1948 26
1949 23
1950 20
1951 31
1952 21
1953 21
1954 20
1955 25
1956 20
1957 26
1958 35
1959 24
1960 32
1961 37
1962 34
1963 53
1964 57
1965 50
1966 78
1967 65
1968 70
1969 94
1970 107
1971 94
1972 96
1973 114
1974 117
1975 98
1976 148
1977 157
1978 152
1979 173
1980 221
1981 209
1982 225
1983 214
1984 214
1985 209
1986 208
1987 246
1988 220
1989 240
1990 253
1991 216
1992 291
1993 248
1994 261
1995 257
1996 250
1997 250
1998 245
1999 284
2000 296
2001 287
2002 301
2003 301
2004 367
2005 343
2006 389
2007 368
2008 406
2009 387
2010 464
2011 434
2012 497
2013 523
2014 575
2015 554
2016 595
2017 603
2018 559
2019 575
2020 655
2021 670
2022 583
2023 568
2024 549
2025 182

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17,805 results

Results by year

Filters applied: . Clear all
Page 1
Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.
Strauss SJ, Frezza AM, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brennan B, Brodowicz T, Buonadonna A, de Álava E, Dei Tos AP, Garcia Del Muro X, Dufresne A, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Gaspar N, Gasperoni S, Gelderblom H, Gouin F, Grignani G, Gronchi A, Haas R, Hassan AB, Hecker-Nolting S, Hindi N, Hohenberger P, Joensuu H, Jones RL, Jungels C, Jutte P, Kager L, Kasper B, Kawai A, Kopeckova K, Krákorová DA, Le Cesne A, Le Grange F, Legius E, Leithner A, López Pousa A, Martin-Broto J, Merimsky O, Messiou C, Miah AB, Mir O, Montemurro M, Morland B, Morosi C, Palmerini E, Pantaleo MA, Piana R, Piperno-Neumann S, Reichardt P, Rutkowski P, Safwat AA, Sangalli C, Sbaraglia M, Scheipl S, Schöffski P, Sleijfer S, Strauss D, Sundby Hall K, Trama A, Unk M, van de Sande MAJ, van der Graaf WTA, van Houdt WJ, Frebourg T, Ladenstein R, Casali PG, Stacchiotti S; ESMO Guidelines Committee, EURACAN, GENTURIS and ERN PaedCan. Electronic address: clinicalguidelines@esmo.org. Strauss SJ, et al. Among authors: jones rl. Ann Oncol. 2021 Dec;32(12):1520-1536. doi: 10.1016/j.annonc.2021.08.1995. Epub 2021 Sep 6. Ann Oncol. 2021. PMID: 34500044 Free article. No abstract available.
Another World.
Jones R. Jones R. Br J Gen Pract. 2019 May;69(682):219. doi: 10.3399/bjgp19X702281. Br J Gen Pract. 2019. PMID: 31023666 Free PMC article. No abstract available.
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment.
Glaviano A, Wander SA, Baird RD, Yap KC, Lam HY, Toi M, Carbone D, Geoerger B, Serra V, Jones RH, Ngeow J, Toska E, Stebbing J, Crasta K, Finn RS, Diana P, Vuina K, de Bruin RAM, Surana U, Bardia A, Kumar AP. Glaviano A, et al. Among authors: jones rh. Drug Resist Updat. 2024 Sep;76:101103. doi: 10.1016/j.drup.2024.101103. Epub 2024 Jun 25. Drug Resist Updat. 2024. PMID: 38943828 Free article. Review.
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).
Gillessen S, Turco F, Davis ID, Efstathiou JA, Fizazi K, James ND, Shore N, Small E, Smith M, Sweeney CJ, Tombal B, Zilli T, Agarwal N, Antonarakis ES, Aparicio A, Armstrong AJ, Bastos DA, Attard G, Axcrona K, Ayadi M, Beltran H, Bjartell A, Blanchard P, Bourlon MT, Briganti A, Bulbul M, Buttigliero C, Caffo O, Castellano D, Castro E, Cheng HH, Chi KN, Clarke CS, Clarke N, de Bono JS, De Santis M, Duran I, Efstathiou E, Ekeke ON, El Nahas TIH, Emmett L, Fanti S, Fatiregun OA, Feng FY, Fong PCC, Fonteyne V, Fossati N, George DJ, Gleave ME, Gravis G, Halabi S, Heinrich D, Herrmann K, Hofman MS, Hope TA, Horvath LG, Hussain MHA, Jereczek-Fossa BA, Jones RJ, Joshua AM, Kanesvaran R, Keizman D, Khauli RB, Kramer G, Loeb S, Mahal BA, Maluf FC, Mateo J, Matheson D, Matikainen MP, McDermott R, McKay RR, Mehra N, Merseburger AS, Morgans AK, Morris MJ, Mrabti H, Mukherji D, Murphy DG, Murthy V, Mutambirwa SBA, Nguyen PL, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Rabah DM, Rathkopf D, Reiter RE, Renard-Penna R, Ryan CJ, Saad F, Sade JP, Sandhu S, Sartor OA, Schaeffer E, Scher HI, Sharifi N, Skoneczna IA, Soule HR, Spratt DE, Srinivas S, Sternberg CN, S… See abstract for full author list ➔ Gillessen S, et al. Among authors: jones rj. Eur Urol. 2025 Feb;87(2):157-216. doi: 10.1016/j.eururo.2024.09.017. Epub 2024 Oct 11. Eur Urol. 2025. PMID: 39394013 Free article.
Models in Occupational Hygiene.
Jones RM. Jones RM. Ann Work Expo Health. 2022 Apr 22;66(4):417-418. doi: 10.1093/annweh/wxac016. Ann Work Expo Health. 2022. PMID: 35388399 No abstract available.
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression.
Vasalou C, Proia TA, Kazlauskas L, Przybyla A, Sung M, Mamidi S, Maratea K, Griffin M, Sargeant R, Urosevic J, Rosenbaum AI, Yuan J, Aluri KC, Ramsden D, Hariparsad N, Jones RDO, Mettetal JT. Vasalou C, et al. Among authors: jones rdo. CPT Pharmacometrics Syst Pharmacol. 2024 Jun;13(6):994-1005. doi: 10.1002/psp4.13133. Epub 2024 Mar 26. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38532525 Free PMC article.
"So, to Recap…".
Jones RC. Jones RC. Anesthesiology. 2024 Jun 1;140(6):1233-1234. doi: 10.1097/ALN.0000000000004943. Anesthesiology. 2024. PMID: 38558057 No abstract available.
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?
Jones DEJ, Beuers U, Bonder A, Carbone M, Culver E, Dyson J, Gish RG, Hansen BE, Hirschfield G, Jones R, Kowdley K, Kremer AE, Lindor K, Mayo M, Mells G, Neuberger J, Prince M, Swain M, Tanaka A, Thorburn D, Trauner M, Trivedi P, Weltman M, Yeoman A, Levy C. Jones DEJ, et al. Among authors: jones r. Hepatology. 2024 Nov 1;80(5):1291-1300. doi: 10.1097/HEP.0000000000000864. Epub 2024 Mar 22. Hepatology. 2024. PMID: 38506926 Free PMC article.
Achieving Osler's Ideal of Imperturbability.
Jones RC. Jones RC. J Gen Intern Med. 2019 Dec;34(12):2901-2902. doi: 10.1007/s11606-019-05234-w. J Gen Intern Med. 2019. PMID: 31432441 Free PMC article. No abstract available.
Immunotherapies for hepatocellular carcinoma.
Liu JKH, Irvine AF, Jones RL, Samson A. Liu JKH, et al. Among authors: jones rl. Cancer Med. 2022 Feb;11(3):571-591. doi: 10.1002/cam4.4468. Epub 2021 Dec 24. Cancer Med. 2022. PMID: 34953051 Free PMC article. Review.
17,805 results
You have reached the last available page of results. Please see the User Guide for more information.